![Ace Report Cover](https://myoe.blob.core.windows.net/images/d89903905e5c270ef8a6f18343654fa4.png)
COA 2024: Local Infiltration Analgesia & Adductor Canal Block After ACLR
![Ace Report Cover](https://myoe.blob.core.windows.net/images/d89903905e5c270ef8a6f18343654fa4.png)
COA 2024: Local Infiltration Analgesia & Adductor Canal Block After ACLR
Comparison of local infiltration analgesia and adductor canal block for pain management following anterior cruciate ligament reconstruction: a systematic review and meta-analysis
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
Four randomized controlled trials with patients undergoing anterior cruciate ligament reconstruction were included in this systematic review and meta-analysis comparing local infiltration analgesia (LIA) versus an adductor canal block (ACB). Pooled outcomes of interest included pain scores at 2, 6, 12, and 24 hours post-surgery and 24-hour opioid consumption. The pooled results showed no statistic...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
![Ace Report Preview Image](https://myoe.blob.core.windows.net/images/AceReport-Blur-LG.jpg)
Learn about our AI Driven
High Impact Search Feature
![High Impact Icon](/Images/High_Impact_Icon.png)
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.